Metier Executives’ Post

The global 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐑𝐨𝐛𝐨𝐭𝐬 market in terms of revenue was estimated to be worth $8.5 billion in 2022 and is poised to reach $18.4 billion by 2027, growing at a CAGR of 16.6% from 2022 to 2027. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐅𝐑𝐄𝐄 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐚𝐭 https://lnkd.in/dhpssQWu North America will account for the largest share of the market. The region's large share can be attributed to the surge in the adoption of surgical robots by hospitals in the country, the increasing volume of robotic-assisted surgical procedures, and the favourable reimbursement policies. 𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: Intuitive Surgical Devices Stryker Medtronic Smith & Nephew, Inc. Zimmer Biomet Asensus Surgical Siemens Healthineers Renishaw CMR Surgical CMR Surgical Brasil THINK Surgical Corin Group PRECEYES B.V. Microsure Titan Medical Inc. avateramedical Digital Solutions GmbH Medicaroid Medicaroid Europe GmbH Medicaroid Asia Pacific Brainlab eCential Robotics Globus Medical Johnson & Johnson Momentis Surgical™ SUDHIR SRIVASTAVA MEDICAL INNOVATIONS PRIVATE LIMITED TINAVI Medical Technologies Co., Ltd Distalmotion Monteris Medical #SurgicalRobots #SurgicalRobotsMarket

𝐓𝐢𝐬𝐬𝐮𝐞 𝐂𝐫𝐲𝐨-𝐞𝐦𝐛𝐞𝐝𝐝𝐢𝐧𝐠 𝐌𝐚𝐜𝐡𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐋𝐚𝐭𝐞𝐬𝐭 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭, 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐅𝐚𝐜𝐭𝐨𝐫𝐬 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟑𝟎 𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 𝗣𝗗𝗙 (𝗜𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗴 𝗙𝘂𝗹𝗹 𝗧𝗢𝗖, 𝗧𝗮𝗯𝗹𝗲 & 𝗙𝗶𝗴𝘂𝗿𝗲𝘀) @ https://lnkd.in/gQQ6XDf3 𝑨𝒄𝒄𝒐𝒓𝒅𝒊𝒏𝒈 𝒕𝒐 𝑳𝒂𝒕𝒆𝒔𝒕 𝑹𝒆𝒔𝒆𝒂𝒓𝒄𝒉 𝑺𝒕𝒖𝒅𝒚, 𝒕𝒉𝒆 𝒈𝒍𝒐𝒃𝒂𝒍 𝒎𝒂𝒓𝒌𝒆𝒕 𝒇𝒐𝒓 𝑻𝒊𝒔𝒔𝒖𝒆 𝑪𝒓𝒚𝒐-𝒆𝒎𝒃𝒆𝒅𝒅𝒊𝒏𝒈 𝑴𝒂𝒄𝒉𝒊𝒏𝒆 𝒔𝒉𝒐𝒖𝒍𝒅 𝒈𝒓𝒐𝒘 𝒇𝒓𝒐𝒎 𝑼𝑺$ 𝒎𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2024 𝒕𝒐 𝑼𝑺$ 𝒎𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2030, 𝒘𝒊𝒕𝒉 𝒂 𝑪𝑨𝑮𝑹 𝒐𝒇 𝑿𝑿% 𝒇𝒐𝒓 𝒕𝒉𝒆 𝒑𝒆𝒓𝒊𝒐𝒅 𝒐𝒇 2024-2030. 𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀 1. Growing Demand for Precision Diagnostics: The demand for personalized medicine and precise diagnostic approach is increasing – thus, increasing demand for good quality tissue cryo-embedding machines. 2. Developments in Cancer Research: Aggressive R&D activities in oncology will require faster preparation of samples thus will increase the market. 3. Growing number of Pathology Labs: Growing number of pathology and Histology labs around the world, especially the emerging economies are fuelling the demand. 4. Government Healthcare Initiatives: Investment in improved diagnostic infrastructure has resulted in investment in the adoption of advanced tissue processing equipment. 𝗧𝗿𝗲𝗻𝗱𝘀: 1. Automation and Smart Technologies: Automation is integrated in order to achieve efficiency and consistency in sample preparation so that results from analyzed tissue, which are more reliable and precise, can be achieved. 2. Compact and User-friendly Design: Manufacturers are putting efforts to retain the compactness and ergonomics of the product with space-saving footprints for full lab integration. 3. Improved Freezing: Better cryo-embedding allows better preservation and sample integrity. 4. These are the exploration features and the performance, driven by the globalization of pathology standards and fast-freezing sample preparation. 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗜𝗻𝗰𝗹𝘂𝗱𝗲: Sartorius Kalstein milestone Microm Microtech Leica Microsystems Sakura Finetek Europe Bioevopeak Jinhua Yidi Medical Appliance CO.,LTD Histo-Line Laboratories Srl Labstac LLC 𝗘𝗻𝗾𝘂𝗶𝗿𝗲 𝗯𝗲𝗳𝗼𝗿𝗲 𝗽𝘂𝗿𝗰𝗵𝗮𝘀𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁, https://lnkd.in/g_EkYD8X Market intelliX Market Pulse Updates #TissueEmbedding #CryoEmbedding #MedicalDevices #HistologyEquipment #BiotechInnovation #TissueProcessing #HealthcareIndustry #LabAutomation #PathologyLabs #TissuePreservation #CryogenicTech #MedicalResearch #MedicalMarket #LifeSciences

🚀 𝐈𝐧𝐭𝐫𝐚𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲: 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐚𝐧𝐝 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧 Get ahead of the curve! 📄 Download the PDF Sample Report Today https://lnkd.in/eGUQZQCc The Intraoperative Imaging market is on a path of remarkable growth, with a projected CAGR of 4.53% from 2024 to 2031. Key drivers? Advancing technologies, rising consumer demand, and expanding applications in sectors like automotive, electronics, and healthcare. 🌍 Emerging economies in Asia-Pacific and Latin America are leading the charge, with rapid industrialization and urbanization boosting the need for cutting-edge #Intraoperative Imaging solutions. ♻️ 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐚𝐬 𝐚 𝐂𝐚𝐭𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 As consumer and government focus shifts to eco-friendly solutions, companies are upping their game. By prioritizing R&D, they're not only innovating but also securing a competitive edge. Strategic alliances, mergers, and acquisitions are also paving the way for expansion, opening doors to new regions and industries. 📊 𝐀 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤 The Global Intraoperative Imaging Market Report dives deep into these trends, providing a full spectrum of insights for the 2024–2031 forecast period. From GDP impact to product penetration and evolving demand across parent and sub-markets, this report is your key to unlocking the industry’s future potential. 🔑 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐞𝐚𝐝𝐞𝐫𝐬 Find out which players are shaping the future of the Intraoperative Imaging industry. 📌 Top Key Players: GE| Siemens| Philips| Medtronic| Medistim ASA| Hitachi| Esaote| Mindray| Neurologica| ANKE Mammography| BK Medical| Perimeter Medical Imaging AI| IMRIS, Deerfield Imaging| KUBTEC Medical Imaging| Invenio Imaging| Body Vision Medical| On Target Laboratories| FUJIFILM Healthcare Asia Pacific| Xoran Technologies| Mobius Imaging, now part of Stryker| Ziehm Imaging| Ziehm Americas| Advanced Digital Pathology Solutions at PreciPoint| Lightpoint| Clarix Imaging| Intellijoint Surgical Inc.| Medistim ASA| META Dynamic, Inc.| CytoVeris | ITEL Healthcare Group| Viseon Inc.| OncoRes Medical| Radlink, Inc.| Irillic Pvt.Ltd.| OR-X| InSyte Bio| Epica Animal Health| SSO Cancer Centre| Pathomation| SurgicEye GmbH| #IntraoperativeImagingIndustry #MarketGrowth #Sustainability #Innovation #EmergingMarkets #TechTrends #MarketInsights #FutureOpportunities

PROCEPT BioRobotics (Nasdaq: PRCT) is facing scrutiny following a report from short seller Spruce Point Capital Management.The investment firm, which is known for its short-selling strategies, challenged the surgical robotics company’s claims of market dominance and raised concerns about its growth projects, product adoption hurdles, and the safety of its Aquablation system. Spruce Point Capital’s report alleges that Procept has exaggerated its addressable market and faces growing competition from less invasive alternatives. #surgicalrobotics

MED-TECH: SS Innovations becomes the first and only company in India to receive regulatory approval for #Telesurgery and #Teleproctoring capabilities, marking a monumental leap in surgical robotics. Click to read: https://lnkd.in/gYYM-A_9 #surgicalrobots #robotics #surgery #India #medtech #medical Edevices #biovoicenews

𝓡𝓮𝓿𝓸𝓵𝓾𝓽𝓲𝓸𝓷𝓲𝓼𝓲𝓷𝓰 𝓗𝓮𝓪𝓵𝓽𝓱𝓬𝓪𝓻𝓮 𝔀𝓲𝓽𝓱 𝓑𝓲𝓸𝓹𝓻𝓲𝓷𝓽𝓲𝓷𝓰 ✴️ 𝑩𝒓𝒆𝒂𝒌𝒕𝒉𝒓𝒐𝒖𝒈𝒉 𝒊𝒏 𝑶𝒓𝒈𝒂𝒏 𝑩𝒊𝒐𝒑𝒓𝒊𝒏𝒕𝒊𝒏𝒈: ✔️ Advanced #3Dprinting technology has successfully produced functional human #organs, marking a pivotal milestone in medicine. ✔️ This innovation addresses the global shortage of donor organs, reducing transplant waiting times and saving lives. ✴️ 𝑪𝒐𝒍𝒍𝒂𝒃𝒐𝒓𝒂𝒕𝒊𝒐𝒏 𝒂𝒏𝒅 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒊𝒄𝒂𝒍 𝑷𝒓𝒐𝒈𝒓𝒆𝒔𝒔: 🤝 Leading research institutions, healthcare organizations, and tech pioneers have collaborated to achieve this breakthrough. 🤝 Functional hearts, kidneys, livers, and other organs have been successfully 3D-printed to closely mimic natural organ structures and functions. ✴️ 𝑨𝒅𝒗𝒂𝒏𝒕𝒂𝒈𝒆𝒔 𝒐𝒇 3𝑫-𝑷𝒓𝒊𝒏𝒕𝒆𝒅 𝑶𝒓𝒈𝒂𝒏𝒔: 💡 Personalization: Tailored to the unique anatomical and physiological needs of patients, reducing rejection risks. 💡 Efficiency: Faster production compared to traditional transplant processes, potentially eliminating long waiting periods. ✴️ 𝑮𝒍𝒐𝒃𝒂𝒍 𝑶𝒓𝒈𝒂𝒏 𝑺𝒉𝒐𝒓𝒕𝒂𝒈𝒆 𝑪𝒓𝒊𝒔𝒊𝒔: ❌ Demand for donor organs has risen by 7% over the past decade. ❌ In 2021, 147,000 transplants were performed globally, with kidneys accounting for 65% of procedures. ❌ Over 110,000 people are on #transplant waiting lists in the US alone, with 20 deaths daily due to organ shortages. ✴️ 𝑩𝒊𝒐𝒑𝒓𝒊𝒏𝒕𝒊𝒏𝒈 𝑴𝒂𝒓𝒌𝒆𝒕 𝑮𝒓𝒐𝒘𝒕𝒉: ⚡ The #bioprinting market, valued at $1.7 billion in 2021, is projected to reach $5.3 billion by 2030. ⚡ Growth drivers include the demand for transplants, successful animal trials, and applications in drug screening and regenerative medicine. ✴️ 𝑭𝒖𝒕𝒖𝒓𝒆 𝑰𝒎𝒑𝒍𝒊𝒄𝒂𝒕𝒊𝒐𝒏𝒔: 🔑 The development of on-demand, personalized organs offers a transformative solution to organ shortages. 🔑 3D bioprinting represents a major leap forward in regenerative medicine, paving the way for a healthier, more sustainable future.

𝗚𝗹𝗼𝗯𝗮𝗹 𝐕𝐞𝐬𝐬𝐞𝐥 𝐒𝐞𝐚𝐥𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐) The global vessel sealing devices market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The report provides a detailed analysis of competitors and regions, offering insights into the industry's landscape. It breaks down various segments, giving a clear view of how each part contributes to the overall market. By examining these segments, the report helps identify trends and patterns that may affect future strategies and planning. 𝐆𝐫𝐚𝐛 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/gdh67RQb 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬: ● 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬: Continuous R&D efforts are leading to the optimization of tissue-sealing algorithms and electrode designs, improving the efficiency and durability of vessel-sealing devices. ● 𝐈𝐧𝐭𝐞𝐠𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐏𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬: The integration of vessel-sealing devices with robotic surgery systems and laparoscopic instruments is enhancing surgical precision and workflow efficiency. ● 𝐄𝐱𝐩𝐚𝐧𝐝𝐢𝐧𝐠 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: The increasing adoption of minimally invasive surgical techniques and the growing demand for advanced surgical tools are driving the market for vessel-sealing devices. 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐕𝐞𝐬𝐬𝐞𝐥 𝐒𝐞𝐚𝐥𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲: BKK B. Braun Melsungen AG BOWA-electronic KG Erbe Elektromedizin GmbH Hologic, Inc. Intuitive Surgical Ltd Johnson & Johnson KLS Martin Group LAMIDEY NOURY MEDICAL Medtronic Plc Olympus Corporation OmniGuide Holdings Inc. Xcellance Medical Technologies Private Limited 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/g_3WZ72d #vesselsealingdevicesmarket #marketresearch #business #marketanalysis #markettrends #researchreport #marketreport #marketforecast #marketgrowth #imarcgroup #businessgrowth #investmentopportunity #industryanalysis

Procept Continues Adoption of Robotic BPH Technology PROCEPT BioRobotics annoucned Q1 2024 earnings, showing continued growth in system placements and increased adoption of the technology with high growth seen in international market expansion. Congratulations Reza Zadno and Stephen McGill on another impressive quarter and continued adoption of the technology. > Total revenue of $44.5 million for the first quarter of 2024, an increase of 83% compared to the prior year period in 2023 > U.S. handpiece and consumables revenue of $23.6 million for the first quarter of 2024, an increase of 101% compared to the prior year period in 2023 > Sold 38 U.S. robotic systems in the first quarter of 2024 > International revenue of $4.3 million for the first quarter of 2024, an increase of 65% compared to the prior year period in 2023 > Increased fiscal year 2024 total revenue guidance to $213.5 million #surgicalrobotics #roboticinnovation #medtech #bph https://lnkd.in/diyD8TeE

As we enter a new week, a few thoughts on #biodesign... A journey I embarked on over a decade ago. Time flies! - And so many moons ago, our team began with the observation that the cost of neck lump biopsies was really high. - The problem was that these high costs were prohibitive: patients weren't getting biopsied early enough due to these high costs, which led to later diagnosis and more severe disease onset. The biopsies were happening too late to be truly helpful. - What was the unmet need initially? - ...There is a need for cheaper neck lump biopsies. - Scoping, research, validation studies... - More research, more validation, more scoping, digging and deep-diving revealed that... - The high costs of neck lump biopsies actually originates from operator-dependency in the neck lump biopsy process -- too many people in the workflow, adding to high costs, which are ultimately passed on to the patient. - We had to... - Reiterate the unmet need! - (Because it wasn't *just* about high costs! Zooming in --> The problem actually lay in the operator-dependency element, all the people in the workflow that added to complexity + costs.) - And so we reiterated the unmet need... - To... - "...An operator-independent way to biopsy neck lumps in the clinic.." - And we next built a new product innovation around this specific unmet need... - i.e. we designed a neck collar with robotic subunit mounted onto a track, for ultrasound-guided neck lump biopsy extraction. - The beauty of the team's new innovation? - ... Neck collar - so in theory, able to be placed on the patient, minimising need for operators in that part of the process. - ... Robotic subunit with ultrasound-guided (and efficient) biopsy taking -- again, minimising operator dependency from needing repeat needle-firing, extraction, analysis. - Designing the innovation to solve the unmet need. - Meeting the problem, where it was at. The #Biodesign process takes you from an observation, to a problem, to a broad unmet need, which needs to be scoped further into a nuanced and well-articulated unmet need. From great unmet needs, teams build meaningful solutions to solve #real #healthcare #problems. If you find this process of exploring problems, narrowing in on the nuance, developing new solutions and working to take them to practise interesting, feel free to get in touch! Happy to share more.

Meet the two key figures leading the upcoming Medical Aesthetic Injectable Summit (MAIS), scheduled for October 4-5, 2024, in Marbella, Spain. They will explain why it's essential for companies specializing in injectable aesthetics and industry analysis to participate in this Summit.   Michel Cheron has been President and CEO of Laboratoires Vivacy since 2008. A pillar in the injectables market, Michel brings over 35 years of experience in the medical device industry.   Dr. Laura Réveillon, Ph.D., Partner at the strategy consulting firm Boston Consulting Group (BCG) will share valuable insights on today’s injectables market and its dynamics.   MAIS is a groundbreaking summit in our profession, gathering leaders from medicine, academia, and industry to explore all aspects of injectables (toxins, HA, non-HA, injecting tools, assist devices, AI, robotics, genomics, and more). From the science behind injectables to product analysis, disruptive technologies to regulations, the program offers a profound look at the past, present, and future of injectables.   Be sure to take a look at the full program: https://lnkd.in/g9D4mzeJ Register with Early Bird rates: https://lnkd.in/g-2GfP6h For sponsors application: https://lnkd.in/grD9__5n